Article

The Efficacy of Food Bioactive Compounds in The Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

2024-10-02

Abstract excerpt

<h4>Background: </h4> Food Bioactive Substances (FBS), extra-nutritional constituents found in foods are promising strategies in the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD). Existing clinical studies showed contradictory results regarding their therapeutic effect. This review aimed to evaluate the effectiveness of food-bioactive substances in patients with NAFLD and non-alcoholic steatohepatitis (NA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c38d7601-309a-53d1-9f29-176db614bb25
DOI: 10.20944/preprints202410.0208.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Efficacy of Food Bioactive Compounds in The Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisDOI 10.20944/preprints202410.0208.v1Read

Clinically Effective Molecules of Natural Origin for Obesity Prevention or TreatmentSemantic proximity Read

Administration of hydro-alcoholic extract of spinach improves oxidative stress and inflammation in high-fat diet-induced NAFLD ratsSemantic proximity Read

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.Semantic proximity Read

Therapeutic potential of algal natural products against metabolic syndrome: A review of recent developmentsSemantic proximity Read

Inhibition of Lipid Accumulation in NAFLD Liver by Extract of Rosa laevigata Fruit Extract through Activation of the PI3K-AKT Signaling PathwaySemantic proximity Read

<i>Lodhrasavam</i> modulates liver–adipose–pancreas axis to ameliorate MASLD: Observations from <i>In vitro</i> and <i>in vivo</i> models of hepatic and metabolic dysfunctionSemantic proximity Read

The Effect of Cardiometabolic Drugs on Non-Alcoholic Fatty Liver Disease (NAFLD), Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Semantic proximity Read

<i>Patolakaturohiniyadi Kashayam</i> , exerts anti-steatotic and anti-obesogenic effects via coordinated regulation of lipid metabolism, inflammation, and incretin signallingSemantic proximity Read

Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.Semantic proximity Read

Efficacy and Safety of GLP-1 Receptor Agonists in Patients with MASLD: A Systematic Review and Meta-analysis of Randomized Clinical TrialsSemantic proximity Read

Effects of Bioactive Compounds in Foods on Metabolic DiseasesSemantic proximity Read

Effects of Bioactive Compounds in the Foods for Prevention of Metabolic syndromeSemantic proximity Read